The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global N-tert-Butoxycarbonyl-4-piperidinol Market Research Report 2025
Synopsis
N-(tert-Butoxycarbonyl)-4-piperidone is also known as N-boc-4-piperidone, where boc is short for t-Butyloxy carbonyl. Also, boc is often adopted as a protecting group in organic synthesis.N-boc-4-piperidone is the derivative of 4-piperidone and is an important pharmaceutical intermediate. N-boc-4-piperidone can be used to synthesize angiotensin-converting enzyme inhibitor (ACEI) (Trandolapril), anti-AIDS protease inhibitor indinavir (Indinavir), etc. The drugs synthesized by it can also treat degenerative diseases, certain cancers and diseases caused by viral, fungi, bacterial infections, etc.
The global N-tert-Butoxycarbonyl-4-piperidinol market was valued at US$ 107.5 million in 2023 and is anticipated to reach US$ 169.1 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
Global key players of N-tert-Butoxycarbonyl-4-piperidinol include Suzhou Highfine Biotech Co, Anhui Dexinjia Biopharm, Shandong Fengyuan Chemical Co, Anhui Rencheng Technology Co, etc. China is the largest producer of N-tert-Butoxycarbonyl-4-piperidinol , holds a share over 70%, followed by North America, Europe, and Japan.
This report aims to provide a comprehensive presentation of the global market for N-tert-Butoxycarbonyl-4-piperidinol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding N-tert-Butoxycarbonyl-4-piperidinol.
Report Scope
The N-tert-Butoxycarbonyl-4-piperidinol market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global N-tert-Butoxycarbonyl-4-piperidinol market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the N-tert-Butoxycarbonyl-4-piperidinol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and by regions.
Market Segmentation
By Company
Suzhou Highfine Biotech Co
Anhui Dexinjia Biopharm
Shandong Fengyuan Chemical Co
Anhui Rencheng Technology Co
Xingtai Xingjiu New Material Technology Co
Suzhou Quanhui Bio-technology Co
Segment by Purity
Min 98%
Other
Segment by Application
Pharmaceutical
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Purity, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of N-tert-Butoxycarbonyl-4-piperidinol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of N-tert-Butoxycarbonyl-4-piperidinol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of N-tert-Butoxycarbonyl-4-piperidinol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
N-(tert-Butoxycarbonyl)-4-piperidone is also known as N-boc-4-piperidone, where boc is short for t-Butyloxy carbonyl. Also, boc is often adopted as a protecting group in organic synthesis.N-boc-4-piperidone is the derivative of 4-piperidone and is an important pharmaceutical intermediate. N-boc-4-piperidone can be used to synthesize angiotensin-converting enzyme inhibitor (ACEI) (Trandolapril), anti-AIDS protease inhibitor indinavir (Indinavir), etc. The drugs synthesized by it can also treat degenerative diseases, certain cancers and diseases caused by viral, fungi, bacterial infections, etc.
The global N-tert-Butoxycarbonyl-4-piperidinol market was valued at US$ 107.5 million in 2023 and is anticipated to reach US$ 169.1 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
Global key players of N-tert-Butoxycarbonyl-4-piperidinol include Suzhou Highfine Biotech Co, Anhui Dexinjia Biopharm, Shandong Fengyuan Chemical Co, Anhui Rencheng Technology Co, etc. China is the largest producer of N-tert-Butoxycarbonyl-4-piperidinol , holds a share over 70%, followed by North America, Europe, and Japan.
This report aims to provide a comprehensive presentation of the global market for N-tert-Butoxycarbonyl-4-piperidinol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding N-tert-Butoxycarbonyl-4-piperidinol.
Report Scope
The N-tert-Butoxycarbonyl-4-piperidinol market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global N-tert-Butoxycarbonyl-4-piperidinol market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the N-tert-Butoxycarbonyl-4-piperidinol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and by regions.
Market Segmentation
By Company
Suzhou Highfine Biotech Co
Anhui Dexinjia Biopharm
Shandong Fengyuan Chemical Co
Anhui Rencheng Technology Co
Xingtai Xingjiu New Material Technology Co
Suzhou Quanhui Bio-technology Co
Segment by Purity
Min 98%
Other
Segment by Application
Pharmaceutical
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Purity, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of N-tert-Butoxycarbonyl-4-piperidinol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of N-tert-Butoxycarbonyl-4-piperidinol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of N-tert-Butoxycarbonyl-4-piperidinol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 N-tert-Butoxycarbonyl-4-piperidinol Market Overview
1.1 Product Definition
1.2 N-tert-Butoxycarbonyl-4-piperidinol Segment by Purity
1.2.1 Global N-tert-Butoxycarbonyl-4-piperidinol Market Value Growth Rate Analysis by Purity 2023 VS 2030
1.2.2 Min 98%
1.2.3 Other
1.3 N-tert-Butoxycarbonyl-4-piperidinol Segment by Application
1.3.1 Global N-tert-Butoxycarbonyl-4-piperidinol Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global N-tert-Butoxycarbonyl-4-piperidinol Production Estimates and Forecasts (2019-2030)
1.4.4 Global N-tert-Butoxycarbonyl-4-piperidinol Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production Market Share by Manufacturers (2019-2024)
2.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of N-tert-Butoxycarbonyl-4-piperidinol, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global N-tert-Butoxycarbonyl-4-piperidinol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global N-tert-Butoxycarbonyl-4-piperidinol Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of N-tert-Butoxycarbonyl-4-piperidinol, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of N-tert-Butoxycarbonyl-4-piperidinol, Product Offered and Application
2.8 Global Key Manufacturers of N-tert-Butoxycarbonyl-4-piperidinol, Date of Enter into This Industry
2.9 N-tert-Butoxycarbonyl-4-piperidinol Market Competitive Situation and Trends
2.9.1 N-tert-Butoxycarbonyl-4-piperidinol Market Concentration Rate
2.9.2 Global 5 and 10 Largest N-tert-Butoxycarbonyl-4-piperidinol Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 N-tert-Butoxycarbonyl-4-piperidinol Production by Region
3.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value by Region (2019-2030)
3.2.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of N-tert-Butoxycarbonyl-4-piperidinol by Region (2025-2030)
3.3 Global N-tert-Butoxycarbonyl-4-piperidinol Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global N-tert-Butoxycarbonyl-4-piperidinol Production by Region (2019-2030)
3.4.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of N-tert-Butoxycarbonyl-4-piperidinol by Region (2025-2030)
3.5 Global N-tert-Butoxycarbonyl-4-piperidinol Market Price Analysis by Region (2019-2024)
3.6 Global N-tert-Butoxycarbonyl-4-piperidinol Production and Value, Year-over-Year Growth
3.6.1 North America N-tert-Butoxycarbonyl-4-piperidinol Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe N-tert-Butoxycarbonyl-4-piperidinol Production Value Estimates and Forecasts (2019-2030)
3.6.3 China N-tert-Butoxycarbonyl-4-piperidinol Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan N-tert-Butoxycarbonyl-4-piperidinol Production Value Estimates and Forecasts (2019-2030)
4 N-tert-Butoxycarbonyl-4-piperidinol Consumption by Region
4.1 Global N-tert-Butoxycarbonyl-4-piperidinol Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global N-tert-Butoxycarbonyl-4-piperidinol Consumption by Region (2019-2030)
4.2.1 Global N-tert-Butoxycarbonyl-4-piperidinol Consumption by Region (2019-2024)
4.2.2 Global N-tert-Butoxycarbonyl-4-piperidinol Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America N-tert-Butoxycarbonyl-4-piperidinol Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America N-tert-Butoxycarbonyl-4-piperidinol Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe N-tert-Butoxycarbonyl-4-piperidinol Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe N-tert-Butoxycarbonyl-4-piperidinol Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific N-tert-Butoxycarbonyl-4-piperidinol Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific N-tert-Butoxycarbonyl-4-piperidinol Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa N-tert-Butoxycarbonyl-4-piperidinol Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa N-tert-Butoxycarbonyl-4-piperidinol Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Purity
5.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production by Purity (2019-2030)
5.1.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production by Purity (2019-2024)
5.1.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production by Purity (2025-2030)
5.1.3 Global N-tert-Butoxycarbonyl-4-piperidinol Production Market Share by Purity (2019-2030)
5.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value by Purity (2019-2030)
5.2.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value by Purity (2019-2024)
5.2.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value by Purity (2025-2030)
5.2.3 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value Market Share by Purity (2019-2030)
5.3 Global N-tert-Butoxycarbonyl-4-piperidinol Price by Purity (2019-2030)
6 Segment by Application
6.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production by Application (2019-2030)
6.1.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production by Application (2019-2024)
6.1.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production by Application (2025-2030)
6.1.3 Global N-tert-Butoxycarbonyl-4-piperidinol Production Market Share by Application (2019-2030)
6.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value by Application (2019-2030)
6.2.1 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value by Application (2019-2024)
6.2.2 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value by Application (2025-2030)
6.2.3 Global N-tert-Butoxycarbonyl-4-piperidinol Production Value Market Share by Application (2019-2030)
6.3 Global N-tert-Butoxycarbonyl-4-piperidinol Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Suzhou Highfine Biotech Co
7.1.1 Suzhou Highfine Biotech Co N-tert-Butoxycarbonyl-4-piperidinol Corporation Information
7.1.2 Suzhou Highfine Biotech Co N-tert-Butoxycarbonyl-4-piperidinol Product Portfolio
7.1.3 Suzhou Highfine Biotech Co N-tert-Butoxycarbonyl-4-piperidinol Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Suzhou Highfine Biotech Co Main Business and Markets Served
7.1.5 Suzhou Highfine Biotech Co Recent Developments/Updates
7.2 Anhui Dexinjia Biopharm
7.2.1 Anhui Dexinjia Biopharm N-tert-Butoxycarbonyl-4-piperidinol Corporation Information
7.2.2 Anhui Dexinjia Biopharm N-tert-Butoxycarbonyl-4-piperidinol Product Portfolio
7.2.3 Anhui Dexinjia Biopharm N-tert-Butoxycarbonyl-4-piperidinol Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Anhui Dexinjia Biopharm Main Business and Markets Served
7.2.5 Anhui Dexinjia Biopharm Recent Developments/Updates
7.3 Shandong Fengyuan Chemical Co
7.3.1 Shandong Fengyuan Chemical Co N-tert-Butoxycarbonyl-4-piperidinol Corporation Information
7.3.2 Shandong Fengyuan Chemical Co N-tert-Butoxycarbonyl-4-piperidinol Product Portfolio
7.3.3 Shandong Fengyuan Chemical Co N-tert-Butoxycarbonyl-4-piperidinol Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Shandong Fengyuan Chemical Co Main Business and Markets Served
7.3.5 Shandong Fengyuan Chemical Co Recent Developments/Updates
7.4 Anhui Rencheng Technology Co
7.4.1 Anhui Rencheng Technology Co N-tert-Butoxycarbonyl-4-piperidinol Corporation Information
7.4.2 Anhui Rencheng Technology Co N-tert-Butoxycarbonyl-4-piperidinol Product Portfolio
7.4.3 Anhui Rencheng Technology Co N-tert-Butoxycarbonyl-4-piperidinol Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Anhui Rencheng Technology Co Main Business and Markets Served
7.4.5 Anhui Rencheng Technology Co Recent Developments/Updates
7.5 Xingtai Xingjiu New Material Technology Co
7.5.1 Xingtai Xingjiu New Material Technology Co N-tert-Butoxycarbonyl-4-piperidinol Corporation Information
7.5.2 Xingtai Xingjiu New Material Technology Co N-tert-Butoxycarbonyl-4-piperidinol Product Portfolio
7.5.3 Xingtai Xingjiu New Material Technology Co N-tert-Butoxycarbonyl-4-piperidinol Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Xingtai Xingjiu New Material Technology Co Main Business and Markets Served
7.5.5 Xingtai Xingjiu New Material Technology Co Recent Developments/Updates
7.6 Suzhou Quanhui Bio-technology Co
7.6.1 Suzhou Quanhui Bio-technology Co N-tert-Butoxycarbonyl-4-piperidinol Corporation Information
7.6.2 Suzhou Quanhui Bio-technology Co N-tert-Butoxycarbonyl-4-piperidinol Product Portfolio
7.6.3 Suzhou Quanhui Bio-technology Co N-tert-Butoxycarbonyl-4-piperidinol Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Suzhou Quanhui Bio-technology Co Main Business and Markets Served
7.6.5 Suzhou Quanhui Bio-technology Co Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 N-tert-Butoxycarbonyl-4-piperidinol Industry Chain Analysis
8.2 N-tert-Butoxycarbonyl-4-piperidinol Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 N-tert-Butoxycarbonyl-4-piperidinol Production Mode & Process
8.4 N-tert-Butoxycarbonyl-4-piperidinol Sales and Marketing
8.4.1 N-tert-Butoxycarbonyl-4-piperidinol Sales Channels
8.4.2 N-tert-Butoxycarbonyl-4-piperidinol Distributors
8.5 N-tert-Butoxycarbonyl-4-piperidinol Customers
9 N-tert-Butoxycarbonyl-4-piperidinol Market Dynamics
9.1 N-tert-Butoxycarbonyl-4-piperidinol Industry Trends
9.2 N-tert-Butoxycarbonyl-4-piperidinol Market Drivers
9.3 N-tert-Butoxycarbonyl-4-piperidinol Market Challenges
9.4 N-tert-Butoxycarbonyl-4-piperidinol Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
